HomeGANX • NASDAQ
add
Gain Therapeutics Inc
Previous close
$3.18
Day range
$3.10 - $3.32
Year range
$2.00 - $6.19
Market cap
51.09M USD
Avg Volume
105.58K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 0.00 | — |
Operating expense | 2.18M | -10.52% |
Net income | -4.72M | -1.06% |
Net profit margin | — | — |
Earnings per share | -0.29 | 25.64% |
EBITDA | -4.40M | 3.67% |
Effective tax rate | -0.31% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 16.79M | -16.60% |
Total assets | 18.61M | -22.78% |
Total liabilities | 6.03M | 15.54% |
Total equity | 12.58M | — |
Shares outstanding | 16.22M | — |
Price to book | 4.08 | — |
Return on assets | -67.39% | — |
Return on capital | -100.30% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -4.72M | -1.06% |
Cash from operations | -5.66M | -44.97% |
Cash from investing | 3.14M | 2,247.65% |
Cash from financing | 9.56M | 44,398.94% |
Net change in cash | 7.53M | 311.01% |
Free cash flow | -2.97M | -60.59% |
About
Founded
2017
Website
Employees
31